News

With pipette tips, P2i uses its cold plasma-enhanced chemical vapour deposition process to apply nano-thin coatings which enhance their performance, virtually eliminating liquid retention.

The PG200 is designed to offer an advanced workflow and powerful data analysis for the proteomics researcher.

National Cancer Institute (NCI) has chosen InforSense technology for high-throughput genetic data analysis in cancer research.

Ciphergen will provide its suite of proteomic solutions designed for biomarker discovery and development of assays, to analyze patients' tumor cyst fluid and blood samples collected at University of Kentucky Healthcare.

Affibody AB and Agilent Technologies Inc. have announced an agreement to develop advanced protein sample preparation solutions for human biomarker discovery.

This multi-scale protein modeling approach may reduce the time it takes to bring pharmaceuticals to market and may have significant implications for an array of biotechnology applications

Ciphergen will provide its suite of proteomic solutions designed for biomarker discovery and development of assays, to analyze patients' tumor cyst fluid and blood samples collected at University of Kentucky Healthcare.

The executive teams of five major molecular interaction databases have announced the signing of an agreement to share curation efforts and exchange completed records.

A recent CTRC study demonstrated the potential of focusing on an individual's protein composition, and levels of certain proteins associated with particular cancers.

Organon elected to continue the collaboration by accepting the latest preclinical lead candidate generated by Pharmacopeia's drug discovery and development platform.